These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 210551)

  • 41. [The effects of the parathyroid hormone, calcium and calcitonin on plasma and urinary C-nucleotides in parathyroid disorders (author's transl)].
    Nakagawa H
    Nihon Naibunpi Gakkai Zasshi; 1979 Nov; 55(11):1437-51. PubMed ID: 230098
    [No Abstract]   [Full Text] [Related]  

  • 42. [Determination of urinary cyclic AMP in 15 cases of primary hyperparathyroidism].
    Camus JP; Desgrez P; Guillemant S; Crouzet J
    Ann Med Interne (Paris); 1975; 126(8-9):594-600. PubMed ID: 175731
    [No Abstract]   [Full Text] [Related]  

  • 43. [Urinary cyclic AMP and nephrogenous cyclic AMP in the diagnosis of parathyroid disorders (author's transl)].
    Sohn HW
    Nihon Naibunpi Gakkai Zasshi; 1980 Jun; 56(6):804-17. PubMed ID: 6250920
    [No Abstract]   [Full Text] [Related]  

  • 44. PTH-infusion and estimation of urinary cAMP in hyperparathyroidism.
    von Lilienfeld-Toal H; Hüfner M; Hesch RD
    Acta Endocrinol Suppl (Copenh); 1973; 173():164. PubMed ID: 4353563
    [No Abstract]   [Full Text] [Related]  

  • 45. [Investigation of the causes of urolithiasts. I. Calcium metabolism, with special reference to serum ionized calcium (author's transl)].
    Iguchi M; Nagai N; Matsuura T; Kaneko S; Kohri K; Minami K; Kadowaki T; Akiyama T; Yachiku S; Kurita T; Nakamoto J; Ohba Y
    Nihon Hinyokika Gakkai Zasshi; 1978 May; 69(5):578-84. PubMed ID: 671914
    [No Abstract]   [Full Text] [Related]  

  • 46. Urinary cyclic adenosine monophosphate as an aid in the diagnosis of hyperparathyroidism.
    Neelon FA; Birch BM; Drezner M; Lebovitz HE
    Lancet; 1973 Mar; 1(7804):631-3. PubMed ID: 4121845
    [No Abstract]   [Full Text] [Related]  

  • 47. Relative contribution of various expressions of cAMP excretion to other indices of parathyroid function, as tested by discriminant multivariate linear regression analysis.
    Valsamis J; Van Peborgh J; Brauman H
    Clin Chem; 1986 Jul; 32(7):1279-84. PubMed ID: 3013464
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Peculiarities of primary hyperparathyroidism in childhood].
    Röher HD; Wahl AR; Schmidt-Gayk H
    Chirurg; 1975 Nov; 46(11):512-7. PubMed ID: 173500
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Evaluation of serum ionized calcium before and after parathyroidectomy in primary hyperparathyroidism (author's transl)].
    Itatani H; Takemoto M; Yachiku S; Kotake T; Kinoshita K
    Nihon Hinyokika Gakkai Zasshi; 1974 Oct; 65(10):633-6. PubMed ID: 4477344
    [No Abstract]   [Full Text] [Related]  

  • 50. [The calcium-AMPc test in the classification of hypercalciurias].
    Aubia J; Camps J; López-Pedret J; Rivera F; Revert L
    Actas Urol Esp; 1978; 2(1):19-22. PubMed ID: 208354
    [No Abstract]   [Full Text] [Related]  

  • 51. [Usefulness of changes in urinary P/Cr ratio as a diagnostic parameter in primary hyperparathyroidism].
    Kitamura T; Moriyama N; Kawabe K; Aso Y
    Nihon Hinyokika Gakkai Zasshi; 1988 Jun; 79(6):1085-9. PubMed ID: 3184583
    [No Abstract]   [Full Text] [Related]  

  • 52. [Endocrinological studies on pathogenesis of urolithiasis. I. Characteristics of cyclic AMP (author's transl)].
    Kohri K; Yachiku S; Kurita T
    Nihon Hinyokika Gakkai Zasshi; 1980 Jun; 71(6):614-25. PubMed ID: 6253702
    [No Abstract]   [Full Text] [Related]  

  • 53. Comparison of two parathyrin (PTH) assays misleading?
    Kao PC; Klee G
    Clin Chem; 1987 May; 33(5):744-5. PubMed ID: 3568388
    [No Abstract]   [Full Text] [Related]  

  • 54. Somatostatin decreases urinary calcium excretion.
    Lins PE; Efendic S; Löw H
    Lancet; 1978 Sep; 2(8091):687. PubMed ID: 80623
    [No Abstract]   [Full Text] [Related]  

  • 55. More on testing for hyperparathyroidism.
    Hawker CD
    Clin Chem; 1986 Dec; 32(12):2224-5. PubMed ID: 3779999
    [No Abstract]   [Full Text] [Related]  

  • 56. [Autonomous hyperparathyroidism--diagnostic values of laboratory parameters (author's transl)].
    Hering F; Lutzeyer W
    Urologe A; 1978 Jul; 17(4):220-2. PubMed ID: 210551
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Hyperparathyroidism secondary to cirrhosis. Arguments supplied by ionized calcium, urinary cyclic AMP and blood N-terminal parathyroid hormone].
    Louboutin JY; Feuillu A; Allain H; Bernat M; Meadeb J; Pawlotsky Y
    Rev Rhum Mal Osteoartic; 1980 Dec; 47(12):707-13. PubMed ID: 6256846
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Value and relevance of metabolic function tests in the diagnosis of primary hyperparathyroidism (author's transl)].
    Schweigart U; Henderkott U; Paterek K; Hartung R; Zilker T; Bottermann P
    Med Klin; 1976 Feb; 71(7):281-5. PubMed ID: 176561
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ionized calcium and cyclic AMP in plasma and urine. Biochemical evaluation in calcium metabolic disease.
    Thode J
    Scand J Clin Lab Invest Suppl; 1990; 197():1-45. PubMed ID: 2154030
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Grouping of patients with hyperparathyroidism by clinical signs, correlated to some biochemical findings.
    Andersson R; Gillquist J; Larsson L; Kågedal B
    Acta Chir Scand; 1976; 142(8):567-73. PubMed ID: 202128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.